Fluocortin butyl

In this article, we will explore the different facets of Fluocortin butyl and its impact on today's society. From its historical origins to its relevance today, we will analyze the different aspects that make Fluocortin butyl a topic of interest to a wide variety of people. Through a multidisciplinary approach, we will examine the economic, social, cultural and political implications of Fluocortin butyl, with the aim of understanding its influence on the contemporary world. Likewise, we will immerse ourselves in the debates and controversies that have arisen around this topic, considering different perspectives and opinions to offer a complete overview of its importance. Join us on this tour of Fluocortin butyl and discover its significance today!

Fluocortin butyl
Clinical data
Trade namesLenen, Novoderm, Varlane, Vaspit
Other namesFCB; SHK-203; Fluocortin 21-butylate; Fluocortin butylate; Fluocortolone-21-carboxylate 21-butyl; 6α-Fluoro-11β-hydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-21-oic acid butyl ester
Drug classCorticosteroid; Glucocorticoid
Identifiers
  • Butyl 2-phenanthren-17-yl]-2-oxoacetate
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.050.476 Edit this at Wikidata
Chemical and physical data
FormulaC26H35FO5
Molar mass446.559 g·mol−1
3D model (JSmol)
  • CCCCOC(=O)C(=O)1(C21(C(32C(C4=CC(=O)C=C34C)F)O)C)C
  • InChI=1S/C26H35FO5/c1-5-6-9-32-24(31)23(30)21-14(2)10-17-16-12-19(27)18-11-15(28)7-8-25(18,3)22(16)20(29)13-26(17,21)4/h7-8,11,14,16-17,19-22,29H,5-6,9-10,12-13H2,1-4H3/t14-,16+,17+,19+,20+,21-,22-,25+,26+/m1/s1
  • Key:XWTIDFOGTCVGQB-FHIVUSPVSA-N

Fluocortin butyl (brand names Lenen, Novoderm, Varlane, Vaspit), or fluocortin 21-butylate, is a synthetic glucocorticoid corticosteroid which is marketed in Germany, Belgium, Luxembourg, Spain, and Italy. Chemically, it is the butyl ester derivative of fluocortin.

It was patented in 1971 and approved for medical use in 1977.

References

  1. ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 563–. ISBN 978-1-4757-2085-3.
  2. ^ a b Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 457–. ISBN 978-3-88763-075-1.
  3. ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 487. ISBN 9783527607495.